1. deceived. saw on him - protruding red breakouts on torso-back/the constant
bruising-discolor that won't heal/ the w h o r g/ h o m o -in ce st -b i s e x u al -d i se a se;deceptions.
years of deceptions -oh g-d.
2. military clinic on-base and spouse did not disclose 'true diagnosis of Kaposi's Sarcoma'
infection ;the hushed looks between active duty monster and clinician;
recommended topical cream without full explanation...-tried shrugging it off as something
that'll go away.. .
flashbacks of indignity-the pain!
3. abuses. lies. abuses. black-outs. grooming monster. abuser. sick. passing out.
monster's deceptions. his games. sick.
flash back of what monster did.
d a t e r a p e pills. b l a ck out s. hi d d en cam.
Now used for court documentation. trails of this monster. oh g-d.
.......4.didn't know then such sickness could be right in front of my face...didn't know such monster existed. ..didn't know how to comprehend...didn't have the knowledge then...
5...now, all pieces fit. all his sickness exposed. nauseating. monster. unethical. immortal. monster.
http://www.aidsmap.com/Kaposis-sarcoma/page/1044692/
Kaposi's sarcoma (KS) is an AIDS-defining cancer and was one of the first recognised HIV-related illnesses in the early 1980s.
http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001682/#adam_000661.disease.causes
Skin Cancer (Kaposi Sarcoma) linked to AID-HIV.
(Bruises that are permanent/ protruding lesions on one's torso/back/ lesion on foot)
treatment 1;
. HHV-8 is the virus that causes Kaposi's sarcoma.
If you have HIV-related Kaposi's sarcoma, you will be given a course of combination antiretroviral therapy (cART) to reduce the amount of HIV in the blood to a very low or undetectable level.
As well as cART, you may require treatment with radiotherapy or chemotherapy, depending on the site and extent of the cancer and what symptoms it is causing.
cART
Combination antiretroviral therapy (cART) involves the use of several different medications called antiretroviral therapy to lower HIV levels in the blood by slowing down the rate at which the virus can multiply.
treatment 2;
small skin lesions may be removed using surgery or cryotherapy.
Some small lesions can be removed using a treatment called cryotherapy. This involves freezing the lesions with liquid nitrogen.
Another treatment for small lesions is a gel called retinoic acid applied directly to the skin, usually several times a day. Up to half of people treated with retinoic acid experience an improvement in their lesions after a few weeks of starting treatment.
Common side effects of this treatment include mild irritation and redness.
treatment 3;Endemic African Kaposi's sarcoma is usually treated using a combination of radiotherapy and chemotherapy.
treatment 4; Transplant-related Kaposi's sarcoma is usually treated by reducing or stopping your current treatment with immunosuppressants (if possible), or with immunotherapy.
The aim is to strengthen your immune system enough to fight off the human herpesvirus 8 (HHV-8) while ensuring your body doesn't reject the transplanted organ
Before the AIDS epidemic, Kaposi's sarcoma was seen mainly in elderly Italian and Jewish men, and rarely, in elderly women. Among this group, the tumors developed slowly. In AIDS patients, the cancer can develop quickly. The cancer may also involve the skin, lungs, gastrointestinal tract, and other organs.
Infection with this virus is thought to be lifelong, but a healthy immune system will keep the virus in check. Many people infected with KSHV will never show any symptoms. Kaposi's sarcoma occurs when someone who has been infected with KSHV becomes immunocompromised due to AIDS, medical treatment or very rarely aging.
Since persons infected with KSHV will asymptomatically shed the virus, caution should be used by sex partners in having unprotected sex and activities where saliva might be shared during sexual activity.
Prudent advice is to use commercial lubricants when needed and avoid deep kissing with partners with KSHV and HIV infections or whose status is unknown.
Blood tests to detect infection exist, but they are largely restricted to research universities, since biomedical companies have not found it economical to develop these tests.
Infection with this virus is thought to be lifelong, but a healthy immune system will keep the virus in check. Many people infected with KSHV will never show any symptoms. Kaposi's sarcoma occurs when someone who has been infected with KSHV becomes immunocompromised due to AIDS, medical treatment or very rarely aging.
Since persons infected with KSHV will asymptomatically shed the virus, caution should be used by sex partners in having unprotected sex and activities where saliva might be shared during sexual activity.
Prudent advice is to use commercial lubricants when needed and avoid deep kissing with partners with KSHV and HIV infections or whose status is unknown.
Blood tests to detect infection exist, but they are largely restricted to research universities, since biomedical companies have not found it economical to develop these tests.
Some theories for how the virus spreads include:
- sexual transmission, particularly between men who have unprotected anal sex with other men
- saliva, possibly including kissing
- sharing needles and syringes used for injecting drugs
- from mother to baby during birth
A tissue sample can be taken from almost anywhere on, or in, your body, including the skin, stomach, kidneys, liver and lungs.
An endoscopy may be carried out if it's thought you have Kaposi's sarcoma in your digestive system. It involves inserting a thin, flexible tube called an endoscope down your throat.
This allows the specialist to look inside parts of your digestive system, such as your bowel, liver and spleen, for any abnormalities or signs of Kaposi's sarcoma. A biopsy may be taken if anything suspicious is found.
Classic Kaposi's sarcoma is a rare condition that mainly affects middle-aged and elderly men of Mediterranean or Ashkenazi Jewish descent. Ashkenazi Jews are people who are descended from Jewish communities that lived in central and eastern Europe. Most Jewish people in the UK are Ashkenazi Jews.
It is thought people who develop classic Kaposi's sarcoma were born with a pre-existing genetic vulnerability to the HHV-8 virus.
Kaposi's sarcoma is caused by a virus called the human herpesvirus 8 (HHV-8), also known as the Kaposi's sarcoma-associated herpesvirus (KSHV).
The virus only seems to cause the condition in some people with:
- a weakened immune system – this is thought to be the reason why people develop HIV-related Kaposi's sarcoma and transplant-related Kaposi's sarcoma
- an inherited (genetic) vulnerability to HHV-8 – this is thought to be the reason why people develop either classic Kaposi's sarcoma (Ashkenazi-Jew descendents/ Mediterranean-Italians/ H o m o x u al s) or "endemic" African Kaposi's sarcoma
The internal organs most commonly affected by Kaposi's sarcoma are the lymph nodes, lungs and the digestive system. The symptoms depend on which organs are affected.
When the lymph nodes are affected, there may be swelling in the arms and legs, which can be very painful and uncomfortable.
This is known as lymphoedema. It is caused by tumours blocking the flow of fluid through the lymph nodes. As a result, the fluid in the tissue backs up, causing swelling in the body's tissues.
Where the digestive system is affected, symptoms can include feeling sick (nausea), vomiting, stomach pain and diarrhoea.
Kaposi's sarcoma is a type of cancer that's often found in AIDS patients.
Kaposi's sarcoma is a rare type of cancer that can affect both the skin and internal organs.
The most common initial symptom of Kaposi's sarcoma is the appearance of red or purple patches on the skin. The patches then grow into lumps known as nodules.
Kaposi's sarcoma can also damage the internal organs, which can lead to a range of symptoms, depending on which organs are affected. These can include:
- breathlessness
- bleeding gums
- stomach pain
- leg swelling
Transmitted thru Saliva.
In Europe and North America, KSHV is transmitted through saliva. Thus, kissing is a theoretical risk factor for transmission. Higher rates of transmission among gay and bisexual men have been attributed to "deep kissing" sexual partners with KSHV.[26] Another alternative theory suggests that use of saliva as a sexual lubricant might be a major mode for transmission. Prudent advice is to use commercial lubricants when needed and avoid deep kissing with partners with KSHV infection or whose status is unknown.
KSHV is also transmissible via organ transplantation[27] and blood transfusion.[7] Testing for the virus before these procedures is likely to effectively limit iatrogenic transmission.
Respiratory tract[edit]
Involvement of the airway can present with shortness of breath, fever, cough, hemoptysis (coughing up blood), or chest pain, or as an incidental finding on chest x-ray.[25] The diagnosis is usually confirmed by bronchoscopy when the lesions are directly seen, and often biopsied.
KS lesions are nodules or blotches that may be red, purple, brown, or black, and are usually papular (in other words, palpable or raised).
They are typically found on the skin, but spread elsewhere is common, especially the mouth, gastrointestinal tract andrespiratory tract. Growth can range from very slow to explosively fast, and is associated with significant mortality andmorbidity.[22]
Skin[edit]
Commonly affected areas include the lower limbs, back, face, mouth, and genitalia. The lesions are usually as described above, but may occasionally be plaque-like (often on the soles of the feet) or even involved in skin breakdown with resulting fungating lesions. Associated swelling may be from either local inflammation or lymphoedema (obstruction of locallymphatic vessels by the lesion). Skin lesions may be quite disfiguring for the sufferer,
Mouth[edit]
The mouth is involved in about 30% of cases, and is the initial site in 15% of AIDS-related KS. In the mouth, the hard palate is most frequently affected, followed by the gums.[23] Lesions in the mouth may be easily damaged by chewing and bleed or suffer secondary infection, and even interfere with eating or speaking.
Gastrointestinal tract[edit]
Involvement can be common in those with transplant-related or AIDS-related KS, and it may occur in the absence of skin involvement. The gastrointestinal lesions may be silent or cause weight loss, pain, nausea/vomiting, diarrhea, bleeding (either vomiting blood or passing it with bowel motions), malabsorption, or intestinal obstruction.[24]
Classic Kaposi sarcoma most commonly appears early on the toes and soles as reddish, violaceous, or bluish-black macules and patches that spread and coalesce to form nodules or plaques.[9]:599 A small percentage of these patients may have visceral lesions. In most cases the treatment involves surgical removal of the lesion. The condition tends to be indolent and chronic, affecting elderly men from the Mediterranean region, or of Eastern European descent. Countries bordering the Mediterranean basin have higher rates of KSHV/HHV-8 infection than the remainder of Europe
KS, in fact, arises as a cancer oflymphatic endothelium and forms vascular channels that fill with blood cells, giving the tumor its characteristic bruise-like appearance.
Small, painless flat areas (lesions) usually develop first. The lesions can be different colours, including brown, red, blue and purple. They can look similar to bruises but, unlike bruises, they don't lose their colour when they're pressed.
The lesions are the result of many abnormal cell growths (tumours) affecting small blood vessels under the skin.
Lesions inside the mouth can make speaking and eating more difficult. They can also bleed if they are damaged when chewing.
Although Kaposi's sarcoma growths usually start in one place, they can develop in more than one area. Over time, the growths may start to stick out of the skin and may merge into each other
Kaposi lesions will shrink upon first starting highly active antiretroviral therapy (HAART). However, in a certain percentage of such patients, Kaposi sarcoma may again grow after a number of years on HAART, especially if HIV is not completely suppressed.
AIDS-associated Kaposi sarcoma typically presents with cutaneous lesionsthat begin as one or several red to purple-red macules, rapidly progressing to papules, nodules, and plaques, with a predilection for the head, back, neck, trunk, and mucous membranes. In more advanced cases, they can be found in the stomach and intestines, the lymph nodes, and the lungs.
It has been reported that only 6% of men who have sex with men are aware that KS is caused by a virus different from HIV.[3] Thus, there is little community effort to prevent KSHV infection. Likewise, no systematic screening of organ donations is in place.
In AIDS patients, Kaposi sarcoma is considered an opportunistic infection, a disease that is able to gain a foothold in the body because the immune system has been weakened. With the rise of HIV/AIDS in Africa, where KSHV is widespread, KS has become the most frequently reported cancer in some countries.
Blood tests to detect antibodies against KSHV have been developed and can be used to determine whether a patient is at risk for transmitting infection to their sexual partner, or whether an organ is infected prior to transplantation. However, these tests are not available except as research tools, and, thus, there is little screening for persons at risk for becoming infected with KSHV, such as transplant patients.
Kaposi sarcoma is not curable.
However, in a certain percentage of such patients, Kaposi sarcoma may again grow after a number of years on HAART, especially if HIV is not completely suppressed. Patients with a few local lesions can often be treated with local measures such as radiation therapy or cryosurgery. In general, surgery is not recommended, as Kaposi sarcoma can appear in wound edges. In general, more widespread disease, or disease affecting internal organs, is treated with systemic therapy with interferonalpha, liposomal anthracyclines (such as Doxil) or paclitaxel.
With the decrease in the death rate among AIDS patients receiving new treatments in the 1990s, the incidence and severity of epidemic KS also decreased. However, the number of patients living with AIDS is increasing substantially in the United States, and it is possible that the number of patients with AIDS-associated Kaposi sarcoma will again rise as these patients live longer with HIV infection.
Before the AIDS epidemic, Kaposi's sarcoma was seen mainly in elderly Italian and Jewish men, and rarely, in elderly women. Among this group, the tumors developed slowly. In AIDS patients, the cancer can develop quickly. The cancer may also involve the skin, lungs, gastrointestinal tract, and other organs.
Kaposi's sarcoma
Kaposi's sarcoma. Characteristic violaceous plaques on the alar and tip of the nose in an HIV-positive female patient.
The viral (HHV-8 is responsible for all varieties of KS) cause
\
for this cancer was discovered in 1994.
Kaposi sarcoma (KS) is a tumor caused by human herpesvirus 8 (HHV8, also known as Kaposi's sarcoma-associated herpesvirus, KSHV). It was originally described by Moritz Kaposi (pronounced [ˈkɒ.po.ʃi], ka-pə-shi);
Complications can include:
- Cough (possibly bloody) and shortness of breath if the disease is in the lungs
- Leg swelling that may be painful or cause infections if the disease is in the lymph nodes of the legs
The tumors can return even after treatment. Kaposi's sarcoma can be deadly for a person with AIDS.
the tumors developed slowly. In AIDS patients, the
cancer can develop quickly. The cancer may also
involve the skin, lungs, gastrointestinal tract, and other
organs.
Kaposi's sarcoma on the thigh
Kaposi's sarcoma - lesion on the foot
Kaposi's sarcoma on foot
In people with AIDS, Kaposi's sarcoma is caused by an interaction between HIV, a weakened immune system, and the human herpesvirus-8 (HHV-8). Kaposi's sarcoma has been linked to the spread of HIV and HHV-8 through sexual activity.
People who have kidney or other organ transplants are also at risk for Kaposi's sarcoma.
African Kaposi's sarcoma is fairly common in young adult males living near the equator. One form is also common in young African children.
Symptoms
The tumors most often appear as bluish-red or purple bumps on the skin. They are reddish-purple because they are rich in blood vessels.
The lesions may first appear on the feet or ankles, thighs, arms, hands, face, or any other part of the body. They also can appear on sites inside the body.
Other symptoms may include:
Signs and tests
The following tests may be performed to diagnose Kaposi's sarcoma:
Treatment
How this condition is treated depends on:
- How much the immune system is suppressed (immunosuppression)
- Number and location of the tumors
- Symptoms
Treatments include:
- Antiviral therapy against HIV
- Combination chemotherapy
- Freezing (cryotherapy)
- Radiation therapy
Lesions may return after treatment.
Expectations (prognosis)
Treating Kaposi's sarcoma does not improve the chances of survival from AIDS itself. The outlook depends on the person's immune status and how much of the HIV virus is in the patient's blood (viral load).
Complications
Complications can include:
- Cough (possibly bloody) and shortness of breath if the disease is in the lungs
- Leg swelling that may be painful or cause infections if the disease is in the lymph nodes of the legs
The tumors can return even after treatment. Kaposi's sarcoma can be deadly for a person with AIDS.
An aggressive form of African Kaposi's sarcoma can spread quickly to the bones. Another form found in African children does not affect the skin. Instead, it spreads through the lymph nodes and vital organs, and can quickly become deadly.
Prevention
Safe sexual practices can prevent HIV infection. This prevents AIDS and its complications, including Kaposi's sarcoma.